Butyrolactone I, a selective inhibitor of cdk2 and cdc2 kinase.
Year: 1993
Type: article
Source: PubMed
Authors: M Kitagawa, T Okabe, H Ogino, H Matsumoto, I Suzuki-Takahashi, T Kokubo, H Higashi, S Saitoh, Y Taya, H Yasuda
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2399621249